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ABSTRACT
Paternally expressed gene 3 (Peg3) is an imprinted gene encoding a DNA-binding protein
that is a predicted transcriptional repressor. The two studies presented here demonstrate the
repressive functions of PEG3 in regulating different cellular processes and pathways, which were
observed by analyzing the ChIP-seq results systematically using both bioinformatics tools and
manual inspection of significant peaks. In the first part of the work, genome-wide features of ChIPseq peaks were characterized and the potential de novo binding motif was reevaluated. Results
suggested the transcriptional repressor role of PEG3 by binding to the conserved sequence motif
of the target genes. The results also revealed the unusually higher percentage of distal intergenic
PEG3 peaks, suggesting the potential role of PEG3 by binding to enhancers.
Previous studies have shown that the mutant phenotypes of Peg3 are associated with the
over-expression of genes involved in lipid metabolism. In addition, the initial inspection identified
Acly, Fasn, Idh1, and Hmgcr as potential downstream genes. Therefore, the second part of this
study was focused on assessing the functional role of PEG3 in affecting lipogenesis since these
four genes are the critical genes in the lipogenesis pathway. In vivo binding of PEG3 to the
promoter region of these four key genes was confirmed through individual ChIP experiments. The
opposite response of Acly expression levels against the variable gene dosages of Peg3, involving
0x, 1x, and 2x Peg3 was observed. This confirmed the transcriptional repressor role of Peg3 in the
expression levels of Acly. Another set of analyses showed a sex-biased response in the expression
levels of Acly, Fasn, and Idh1 against 0x Peg3 with higher levels in female and lower levels in
male mammary glands. These results highlighted that Peg3 may be involved in regulating the
expression levels of several key genes in adipogenesis.
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Overall, this study presented in this dissertation contributes to further our understanding of
the regulation and functional aspects of Peg3 and other imprinted genes.

x

CHAPTER I
INTRODUCTION
1.1 Epigenetics
The discovery of the double-helix structure of DNA was one of the greatest leaps in the
field of biology, which led to a domino effect to another shift in scientific discoveries. The central
dogma was unanimously accepted among the scientific communities after the discovery of DNA
as genetic material in the mid-1900s. It is essentially a flow of information from DNA to RNA
through transcription in a unidirectional 5’ to 3’ direction. RNA then is translated to a chain of
amino acids, which carries the 5’ to 3’ information of DNA (Crick, 1968). It was then refuted in
the next few decades with the discovery of the retroviral RNA-dependent DNA polymerase or
reverse transcriptase, which utilizes the RNA template to catalyze the synthesis of DNA (Maniatis
et al., 1976) as well as the discovery of several regulatory non-coding RNAs (Hombach & Kretz,
2016).
Epigenetics originated as an anomaly to classic Mendelian genetics since it could not
explain the presence of the several cell types comprising an organ system. Non-mendelian
inheritance such as random X-chromosome inactivation, mosaic skin color, and variation of
embryonic growth could be a result of the expression of only one of the diploid alleles. Epigenetic
phenomena are derived from the fact that DNA is not a separate entity inside a cell. Instead, it is
wrapped around and in close contact with specialized proteins. This complex is referred to as
chromatin (Kornberg, 1974). Several forms of chromatin are possible due to different
modifications that could happen inside the cell: posttranslational histone modifications, chromatin
remodeling, interaction with noncoding RNAs, and re-shuffling of histone proteins.
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Epigenetics is defined as a study of heritable changes that cause the alteration in gene
expression without any changes in the sequence of DNA (Bird, 2002). As simple as it sounds, it is
far more complicated as there can be so many factors that can affect the expression of a gene,
ranging from biological to environmental factors, and that can occur during any point of
development. Epigenetic modifications could lead to remodeling of chromatin and switch on or
off a gene due to chemical alteration of DNA and its affiliated proteins.
All the major epigenetic phenomena can be broadly broken down into four different
categories that affect the expression of DNA: DNA methylation, Histone modification (acetylation
and methylation), non-coding RNA (ncRNA), and chromatin state. In contrast to genetic
information, environmental changes can also affect epigenetic factors. Furthermore, the epigenetic
alteration can be transgenerationally and/or intergenerationally inherited, affecting the subsequent
generation (Xavier et al., 2019).
1.2 Genomic Imprinting
In sexually reproducing organisms, each parent is responsible for passing one of the two
chromosomes to form a diploid cell. Also, most genes are equally expressed from two copies with
each copy or allele derived from each parent. On the other hand, there is a group of genes that are
exceptions to this inheritance pattern. Genomic imprinting is an epigenetic phenomenon, in which
a small percentage of genes-- around 200 genes in the human genome-- show the parental-specific
monoallelic expression patterns (Barlow, 2011). Imprinted genes are named based on the origin of
expression such as paternally expressed genes with maternal allele being silenced and maternally
expressed genes with paternal allele being silenced. Imprinting was first mentioned by Helen
Crouse when she looked at the effect of deleted paternally derived X-chromosomes in flies
(Crouse, 1960). The true history of genomic imprinting in mammals dates back to the mid-1980s
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when Surani et al. and Solter et al. independently demonstrated the inability to obtain surviving
uniparental androgenetic (with both paternal copies) and gynogenetic (with both maternal copies)
embryos (McGrath & Solter, 1984; Surani et al., 1984). This showed that both parental genomes
are needed for the proper development of an embryo and that both genomes are not interchangeable
functionally.
A typical imprinted domain span is about 100-1,700kb of genomic regions and contains 312 imprinted genes (Edwards & Ferguson-Smith, 2007). Also, a typical imprinted domain is
generally controlled through a cis-acting imprinting control region (ICR). ICRs carry epigenetic
marks of specific parent-of-origin such as DNA methylation and histone modification (Bartolomei,
2009). ICR regions tend to have tandem repeat sequence structures containing DNA binding sites
for CTCF and YY1, which are transcriptional factors (Kim, 2008). When the ICR is deleted, it has
been shown to have a global effect on the proper functioning of its associated domain (Kim, 2008).
ICRs are germline differentially methylated regions (DMRs), which obtain DNA methylation on
one of the two alleles during gametogenesis (Kim et al., 2012). More specifically, the DNA
methylation on maternally imprinted DMR happens during oogenesis, resulting in paternally
expressed genes, whereas DNA methylation on paternally imprinted DMR happens during
spermatogenesis, causing maternally expressed genes (Barlow, 2011). However, during the
primordial germ cell stage of development, these DNA methylation imprints are erased by the
process of Cytosine-phosphate-Guanines (CpGs) demethylation facilitated by Tet1 (Tahiliani et
al., 2009). Overall, discoveries in the field of genomic imprinting have been rapid since it was first
reported in the 80s. Since then, genomic imprinting is associated with regulating a wide range of
processes and pathways throughout the life course of an organism.
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1.3 Functional Role of Imprinted Genes
Imprinted genes account for less than 1% of the total mammalian genome but the
importance of the imprinted genes should not be underestimated. The presence of diploidy (two
functional copies) in the complex multicellular organism masks the effect of deleterious recessive
mutations. Therefore, in the case of imprinted genes, monoallelic expression needs to have some
form of selective advantages over the lack of two functional copies to justify this epigenetic
phenomenon. A few theories have been presented to highlight the selective advantage of genomic
imprinting. One of the most extensively noted theories is the kinship theory, which hinted towards
the evolutionary conflict between the individual alleles derived from each parent. In addition,
kinship theory claimed that the fitness effect on heterozygous offspring would be essential for the
maintenance and evolution of parent-specific expression of imprinted genes (Haig, 2004). This
theory predicted growth enhancers will be paternally expressed, whereas growth inhibitors will be
maternally expressed. It also has been shown that paternal gene biases favored an increased
likelihood of metabolic disease due to a lower rate of brown fat thermogenesis and rapid postnatal
growth. In contrast, maternal gene biases led to lesser muscle mass, higher fat content, lower birth
weight, reduced appetite with lower milk sucking efficacy, and higher insulin level due to reduced
pancreatic -cell mass (Haig, 2004). The theory of kinship was demonstrated through the Insulinlike growth factor 2 (Igf2) and Insulin-like growth factor 2 receptor (Igf2r) imprinted genes. The
Igf2 gene is paternally expressed, whereas the Igf2r gene is maternally expressed (Barlow et al.,
1991; DeChiara et al., 1991). When these genes were inactivated they had an opposite effect on
growth, retardation of growth in Igf2-knockout, and overgrowth in Igf2r-knockout (Ludwig et al.,
1996). The phenotypic effect of Igf2 and Igf2r fits well with the prediction of kinship theory
(Barlow et al., 1991).

4

As described above, one of the important roles of imprinted genes is to play role in survival
and growth. In general, fetal growth is promoted by paternally expressed genes, whereas
maternally expressed genes would act in opposite direction. Imprinted genes, such as Peg10 and
Ascl2, are needed for the development of an embryo and placenta formation, whereas Igf2 and
Slc22a3 are needed for proper nutrient uptake by the fetus (Constância et al., 2002; Guillemot et
al., 1994; Ono et al., 2006; Zwart et al., 2001). Dlk1, Zac1 (Plagl1), Peg1, Gtl2 are expressed in
several tissues to regulate the growth of these tissue during the developmental period (Arima et
al., 2005; Varrault et al., 2006, p. 1).
Imprinted genes also carry out important roles in neural development and behavior after
birth. UBE3A is involved in regulating the protein levels in neurons to maintain normal neuronal
connections in humans and Ndn affects neuronal differentiation and growth (Greer et al., 2010;
Taniura et al., 1999). Newborn pups with a lack of expression of Magel2 have a deficient amount
of oxytocin and would fail at suckling milk. This inability would contribute to a higher probability
of lethality among mutant pups (Schaller et al., 2010). Another interesting observation was a weak
suckling among pups with loss of expression of Gnasxl due to the inadequacy to find and attach to
the mother’s nipple. Alternatively, overexpression of Gnasxl resulted in hyperactivity leading to
the same problem of not getting enough milk among the pups (Fernández-Rebollo et al., 2012;
Fröhlich et al., 2010). Depending on the expression of imprinted genes, post-natal growth could
be accelerated or decelerated [59,60]. It was also demonstrated that a higher level of paternally
imprinted gene expression would increase the appetite and milk sucking ability among mice and
humans (Do et al., 2019; Millership et al., 2019).
Imprinted genes also play important role in stem cells maintenance and renewal (Berg et
al., 2011; Ratajczak et al., 2013; Venkatraman et al., 2013; Zacharek et al., 2011). Many imprinted
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genes, including Peg3, Peg1, Snrpn, and H19, are needed for regulating allele-specific DNA
methylation after reprogramming (Wernig et al., 2007). H19 is involved in the regulation of
hematopoietic adult stem cell populations (Venkatraman et al., 2013). Another study has
highlighted the importance of Dlk1 in postnatal neurogenesis (Ferrón et al., 2011).
Several tumors have been linked to imprinted genes since they play a key role in growth
and development. The higher likelihood of tumorigenesis is heavily linked to the global loss of
imprinting since several imprinted genes, such as Igf2, Peg1, and Peg3, are known as tumor
suppressors (Feinberg, 1999). Loss of imprinting of both imprinted genes, H19 (potent growth
factor gene) and Igf2 (tumor suppressor gene), will lead to tumorigenesis in Wilms’s tumor
(Steenman et al., 1994). Interestingly, a previous study from our lab confirmed the epigenetic
instability in the ICR regions of imprinted domains linked to several human cancers. This
instability in ICRs could disrupt the optimal gene dosage of an imprinted gene, which subsequently
promotes tumorigenesis (Kim et al., 2015).
Overall, imprinting genes play a pivotal role in survival and growth, neural development,
and behavior from prenatal to postnatal to adulthood. It has been well demonstrated that their
expression is very important for two reasons. First, they are monoallelically expressed, so any
mutation or change is likely to show a phenotypic effect. Second, they have been directly linked
to several diseases, including obesity and cancer.
1.4 Paternally Expressed Gene 3 (Peg3) Imprinted Domain
The Paternally Expressed Gene 3 (Peg3) imprinted domain is located on mouse proximal
chromosome 7 and human chromosome 19q13.4. This domain spans about a 500kb region of a
genome and is evolutionarily well conserved among placental mammals (Kim et al., 1997;
Kuroiwa et al., 1996). Peg3 is a part of a larger imprinted domain, which also contains six
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additional imprinted genes; three paternally expressed genes, Ubiquitin-specific hydrolase 29
(Usp29), Antisense Peg3 (Apeg3), and Zinc finger protein 264 (Zfp264) and three maternally
expressed genes; Zinc finger gene, imprinted 1, 2, and 3 (Zim1, Zim2, and Zim3) (Fig 1.1) (He &
Kim, 2014). The presence of the zinc finger motif in their open reading frame makes these genes
DNA-binding transcription factors (He & Kim, 2014). In addition, the presence of about 20 small
genomic fragments in the middle 250kb, also known as evolutionarily conserved regions (ECRs),
take part in regulating the transcription and imprinting of the Peg3 domain [34]. Three DMRs were
discovered in the Peg3 imprinted domain: Peg3-DMR, Zim2-DMR, and Zim3-DMR. The Peg3DMR is the only DMR that acquires its gametic DNA methylation during oogenesis, whereas the
other two are somatic DMRs since they are methylated only after fertilization (Huang & Kim,
2009; Lucifero et al., 2004). In addition, Peg3-DMR as an ICR was further demonstrated by
deletions of this DMR region causing biallelic expression of Zim2, lower expression of Peg3, and
switch of an expressive allele of Zfp264 to maternal from paternal allele (He, Perera, et al., 2016;
Kim et al., 2012).
Similar to several other imprinted genes as discussed earlier, the Peg3 domain also plays
several roles, including regulating fetal growth and development and the behavior of a pup.
Together with Peg3, other genes including Zim1, Zim2, and APeg3 perform critical functions
during embryogenesis and brain development (Kim et al., 1999; Kuroiwa et al., 1996; L. Li et al.,
1999). Mutation of Usp29 in bovine contributed to the stillbirth of calves (Flisikowski et al., 2010).
Overall, the Peg3 domain plays a key role in the growth and development of the embryo and fetus.
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Figure 1.1 Genomic Structure of the Peg3 imprinted domain. Each arrow represents a gene and its
associated arrowhead shows the relative orientation. All the genes in blue color are paternally
expressed genes, whereas genes shown in purple are maternally expressed genes. All three DMR
are shown as a grey box underneath both paternal and maternal allelic genes. Active U1 promoter
is shown in green color, which is responsible for methylation of the Peg3-DMR region on the
maternal allele.
1.5 PEG3 as a DNA Binding Protein
Zinc finger proteins (ZFPs) are one of the most abundant proteins in the eukaryotic
genome. ZFPs were discovered around 35 years ago as a repeated zinc-binding motif in Xenopus
leavis (Miller et al., 1985). They vary widely in structure and function since they are involved in
binding to DNA or RNA, protein-protein interaction, and membrane association. ZFPs are
categorized depending on the order and number of highly conserved Cysteine (Cys) and Histidine
(His) residues. One such abundant motif is C2H2, whose structure contains -framework of
two conserved cysteines (C2) and two conserved histidines (H2) zinc finger modules holding a
zinc ion (Krishna et al., 2003). The zinc ion helps in the stabilization of the secondary structure,
whereas the -helix facilitates the binding to DNA (M. S. Lee et al., 1989; Pavletich & Pabo,
1991). On the other hand, binding specificity depends on the side chain-base interaction of a certain
sequence of amino acid residues present on the helix (Wolfe et al., 2000). All these characteristics
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make them an efficient transcription factor that recognizes the specific DNA sequence to control
the transcription of target genes. Zinc finger domains are associated with varieties of sequence
domains, including the Krüppel-associated box (KRAB) domain and SCAN (SRE-ZBP, Ctfin51,
AW-1, and Number 18) domain (Williams et al., 1999). The KRAB domain is a 75 amino acid
long sequence present at the N-terminus of multiple C2H2 zinc fingers (Bellefroid et al., 1991).
With the help of the KRAB domain, C2H2 ZFPs recruit a co-repressor, KRAB-associated protein1 (KAP-1) for transcriptional repression (Peng et al., 2000). The SCAN domain is a leucine-rich
80-residue long region involved in protein interaction through homo- or hetero-dimer formation
rather than activation or repression of a gene (Williams et al., 1999).
PEG3 belongs to a ZFP family with KRAB and SCAN domains (He, Ye, et al., 2016).
Usually, KRAB recruits KAP1, histone 3 lysine 9 methyltransferase SET domain bifurcated 1
(SETDB1), and histone deacetylases (HDACs) for transcriptional repression of a gene (Urrutia,
2003). In addition to histone methylation silencing, the KAP1 co-repressor forms a
heterochromatin complex on the target gene leading to repression of a gene through physical
interaction (Urrutia, 2003). Both KRAB/KAP1 interaction is also active during early
embryogenesis for DNA methylation as silencing of KRAB-ZFP showed an inability to perform a
maternal imprinting event (X. Li et al., 2008). PEG3 functions as a transcriptional repressor by
binding to DNA and does so through H3K9me3-mediated mechanisms (Ye et al., 2014).
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Figure 1.2 DNA binding activity of PEG3 protein. Blue boxes represent the nine exons of Peg3.
PEG3 domains; SCAN, KRAB, and C2H2 domains are involved in interacting and binding to a
target sequence with the PEG3 binding site. KRAB-ZFP recruits KAP1, SETDB1, and HDACs
for repressing the gene expression through H3K9me3-mediated mechanisms.
1.6 Functional Role of PEG3
Peg3 was discovered around 25 years ago while studying the cDNA library of
parthenogenetic embryos (Kuroiwa et al., 1996). The potential role of Peg3 in the development
and differentiation of the central nervous system and skeletal muscles was suggested in 1996
(Kuroiwa et al., 1996; Relaix et al., 1996). Higher expression of Peg3 was observed in the mouse
tissues like the ovary, placenta, brain, and especially in the hypothalamus, which indicated its
involvement in embryo growth and development (Kim et al., 1997). The monoallelic expression
makes Peg3 an easy target to study the aftermaths of deleterious mutations. This also stresses the
importance of Peg3 expression in many diseases and phenotypes as it has been demonstrated to
have a role in maternal-caring behavior, histone modification, maintaining body temperature,
olfactory alteration, regulating body fat and muscle, and tumor suppression in the ovary, breast,
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and glial cancer (Champagne et al., 2009; Dowdy et al., 2005; Feng et al., 2008; Ghimire & Kim,
2021; Kohda et al., 2001; Ye et al., 2017).
Pups with a mutation on the paternal Peg3 locus have milk sucking defects, which might
subsequently lead to perinatal lethality. The mutational effect is not only limited to pups but also
adult mice (Kim et al., 2013; Swaney et al., 2007, 2008). For instance, Peg3 mutant female mice
exhibited reduced sexual behavior and produced a smaller litter number due to a low number of
eggs in the first place, whereas the pregnant female had a defect in maternal caring, such as milk
letdown and nest building (Champagne et al., 2009; Kim et al., 2013).
Peg3 is also involved in several pathways due to its presence in both the nucleus and
cytoplasm (Deng & Wu, 2000). It is engaged in cellular processes that are linked to cancer. Peg3
was demonstrated to promote the well studied P53-mediated apoptosis pathway by promoting the
translocation of cytoplasmic BAX to mitochondria for neuronal death (Deng & Wu, 2000). PEG3
also interacts with SIAH1A to promote P53-mediated apoptosis in mouse fibroblast cells (Relaix
et al., 2000). When Peg3 was functionally inactivated, it augmented neonatal apoptosis in the
brain. This induced apoptosis, in return, decreased the number of neurons associated with oxytocin
well as impaired the canonical sex-specific differences in brain regions. These regions included
olfaction, reproductive behavior, thermoregulation, and pheromone processing (Broad et al., 2009;
L. Li et al., 1999). Another instance of the role of Peg3 in cancer has been demonstrated, bolstering
its potential tumor suppressor role. For example, hypermethylation of PEG3-DMR is linked with
human ovarian and breast cancer patients in which these patients lose expression of PEG3 (Dowdy
et al., 2005; Feng et al., 2008).
Peg3 has been associated with an important role in the maintenance and function of adult
stem cells populations. The presence of a very high percentage of Peg3-positive adult stem cells
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in the first passage of neuronal progenitors highlights the Peg3 expression being confined to stem
cells and its progenitors' cell population (Besson et al., 2011). Bessen et al. also showed the ability
of Peg3-positive cells to self-proliferate and differentiate (Besson et al., 2011). Together these
observations stress the functional role of Peg3 on adult stem cells.
1.7 Statement of Research Objectives.
Since its genesis over three decades ago, there has been extensive research in the field of
genomic imprinting and their role in embryonic growth and development have been well
characterized. However, there are still so many things yet to be answered. Of a few hundred
identified imprinted genes, only a handful have been extensively studied, and we still don’t know
how the rest of those imprinted genes are regulated and the functions they might involve. One such
well-studied gene is Peg3, where recently it was discovered that an alternative promoter might be
responsible for the silencing of the maternal allele. However, we still don’t know much about its
protein function and its effect on several downstream genes involved in multiple cellular and
biological processes and pathways. The first aim of this work is to present a genome-wide
evaluation of downstream genes of Peg3 to identify a novel DNA binding motif and appraise the
potential novel functional roles of the PEG3. The second aim of this work is to examine the role
of PEG3 in controlling the lipogenesis pathway through Acly.
In the following studies, we evaluate the genome-wide functional role of PEG3. The first
part of the study examines ChIP-seq data systematically to identify and characterize the significant
peaks of Peg3. Results suggest that PEG3 binds to the promoter and potential distal enhancer
regions to regulate transcription as well as several biological processes and pathways. The second
part concentrates on the role of PEG3 in controlling lipogenesis through Acly and other key genes,
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including Idh1, Fasn, and Hmgcr in a sex-specific manner. Overall, this study illustrates the
genome-wide regulation and function of PEG3 as a DNA binding protein.
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CHAPTER II
CHIP-SEQ DOWNSTREAM ANALYSIS OF PEG3
2.1 Introduction
Paternally expressed gene (Peg3) is one of the few hundred mammalian imprinting genes,
which has a known DNA-binding function of transcription repression (Barlow & Bartolomei,
2014). This gene is localized in human chromosome 19q13.4/proximal mouse chromosome 7 (Kim
et al., 1997). Peg3 is also a part of the Peg3 imprinting domain, which also has six additional
imprinting genes (He & Kim, 2014). Peg3 is only active in the paternally derived allele, whereas
it is silenced in the maternal allele (Kuroiwa et al., 1996). This is due to the methylation of 4kb
promoter regions of Peg3 during oogenesis (Huang & Kim, 2009). The presence of cis-regulatory
elements, also known as evolutionarily conserved regions (ECRs), is associated with controlling
and regulating the imprinting domain (Wan & Bartolomei, 2008). Peg3 is involved in regulating
several functions from the organismal level to the cellular level. Its role in controlling fetal growth
rates and maternal caring behaviors has been demonstrated in several studies (Kim et al., 2013; L.
Li et al., 1999). Hypermethylation of PEG3 in patients with breast and ovary cancer has also
implicated its role as a potential tumor suppressor (Dowdy et al., 2005; Feng et al., 2008). Peg3
can also potentially affect global acetylation level through the MSL complex during the
mammalian developmental stage (Ye et al., 2017). Overall, Peg3 has been demonstrated to have a
role in maternal-caring behavior, histone modification, maintaining body temperature, olfactory
alteration, regulating body fat and muscle, and tumor suppression in various cancers (Champagne
et al., 2009; Dowdy et al., 2005; Feng et al., 2008; Ghimire & Kim, 2021; Kohda et al., 2001; Ye
et al., 2017).
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Peg3 belongs to the zinc finger containing (ZNF) protein family and encodes C2H2,
kruppel-type zinc finger protein (Kim et al., 1997). Relaix et al. identified the 8.5kb long Peg3
transcript and its protein, which contains 12 C2H2 zinc finger motifs (Kim et al., 1997; Relaix et
al., 2000). PEG3 contains the C2H2 zinc finger motif at the C-terminus and SCAN and KRAB
domains at the N-terminus (He, Ye, et al., 2016; Relaix et al., 2000; Rimsa et al., 2013). Another
study exhibited that the KRAB domain is involved in the repression of the gene. KRAB-ZFP
recruits KRAB-A box-associated protein 1 (KAP1), histone H3 lysine 9 methyltransferase SET
domain bifurcated 1 (SETDB1), and histone deacetylases (HDACs) for transcriptional repression
of a gene (Urrutia, 2003). In addition to histone methylation silencing, the KAP1 co-repressor
forms a heterochromatin complex on the target gene leading to repression of a gene through
physical interaction (Urrutia, 2003). Studies from our lab have confirmed the binding ability of
Peg3 to several downstream genes and demonstrated Peg3 as a repressor of the transcription of its
downstream genes (S. Lee et al., 2015; Thiaville, Huang, et al., 2013; Ye et al., 2016). Another
study looking at the microarray profile of the Peg3 gene revealed the downregulation of several
placenta-specific gene families in Peg3 mutant embryos (Kim et al., 2013). Similarly, a recent
study from our lab validated the repressor role of Peg3 in the transcription regulation of H19 and
Igf2 (Ye et al., 2016). Our group also further characterized and verified the consensus 8 base long
DNA-binding motif of PEG3, 5’-GTGGCAGT-3’ using ChIP-seq data from adult mouse brain (S.
Lee et al., 2015). This result was consistent with the 2013 study, where a 12 base longer DNAbinding motif was defined (Thiaville, Huang, et al., 2013). Although shorter in length, the newly
defined motif still had all the critical bases that are essential for binding of PEG3.
We analyzed previous ChIP-Seq results from our lab obtained from mouse embryonic
fibroblast (MEF) cells more thoroughly in the current study using current bioinformatic tools in
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order to characterize the function of PEG3. The rationale behind this extensive downstream
analysis of ChIP-seq data was to perform systematic bioinformatics analysis since the previous
study was only focused on finding gene targets of Peg3. With the set of raw sequence files, we
further confirmed the known Peg3 function with the known motifs database comparison and even
identified a potential de novo motif. We also did a distribution analysis of the peak to verify its
binding sites relative to the transcription start sites (TSS) on a few hundred downstream genes. We
then performed the gene ontology and KEGG pathway analysis to identify the potential role of
PEG3 function. The details of our findings are described below in the results section.
2.2 Materials and Methods
ChIP-seq library construction and sequencing
Mouse embryonic fibroblast (MEF) cells from wildtype Peg3 (WT) and conditional
knockout ready Peg3 (KO) were used to prepare the sample using the method previously described
(Thiaville, Kim, et al., 2013). In summary, samples were homogenized and crosslinked with 1%
formaldehyde. After a 30 minute crosslinking process, it was then lysed with a buffer containing
protease inhibitor cocktail (Millipore, Cat. No. 539131). DNA fragments for each sample were
derived after sonication, which was then immunoprecipitated with a commercial anti-PEG3
antibody (Abcam, Cat. No. ab99252). The immunoprecipitated DNA and input DNA obtained
from each sample were used for constructing the libraries for ChIP-seq analysis using Illumina
protocol (Illumina FC4014003). Following the protocol, around 32 million reads on average from
four libraries were derived. For each of the sample files, raw fastq files were quality checked using
fastqc and mutliqc before proceeding to alignment and chip prediction (Table 2.1). All the
associated raw and processed data have been deposited into the Gene Expression Omnibus (GEO)
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database under the accession number GSE181069. Details of programs utilized for full
computational analysis of the data are listed in Table A2.1.
Table 2.1 Sequencing information for four ChIP-seq samples. All the samples (WT, KO,
and two inputs) used for this study were obtained from 14.5 dpc MEF cells and utilized for mutliqc
analysis.

Comparison between ChIP-seq reads and the reference genome
The raw fastq files were mapped to a mm10 mouse reference genome sequence using
Bowtie2 version 2.3.5.1 (Langmead et al., 2009). Sam files were filtered out for unaligned and
random genes and converted to bam files. One of the bam files belonging to the knockout sample
(37M raw reads) was subsampled to match both input and Peg3 bam files. Bam files were then
sorted and used for peak prediction using MACS2 (Y. Zhang et al., 2008). All the MACS2 outputs
are available in appendix A (Table A2.2 and Table A2.3).
Identification of genome-wide PEG3 binding peaks
MACS2 version 2.2.6 was used to perform a peak calling analysis on the processed bam
files. The q-value was set as 0.05 to filter out the false positives and only select the significant
peaks in the enrichment areas compared to the corresponding input bam file. The output peak files
were further processed and converted to bed format for motif discovery and gene annotations.
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Differential binding of Peg3 in WT and KO sample
An executable perl script “getDifferentialPeaks.pl” within HOMER version 4.11 was used
for calling differential peaks between WT and KO samples (Heinz et al., 2010). This script utilizes
the R/Bioconductor and DESeq2 to find the differentially enriched regions between sets of genes.
Output files will have a list of genes with log2foldchange and p-values. On the other hand, the R
based function of program, ngs.plot.r, was used for the visualization of the enrichment of genomic
signals around certain specific regions, such as transcription start sites (TSS) and transcription end
site (TES) (Shen et al., 2014). Further, the same function was utilized to generate the metaprofile
plot of our ChIP-seq data comparing WT to KO at the ± 3kb regions of TSS.
Annotation and feature analysis of PEG3 target genes
ChIPseeker, an R language package, was used to identify the overall features of target
genes. It supports annotating ChIP peaks and generating the visualization for coverage of ChIP
peaks over the mouse chromosomes as well as the overall peaks profile in relation to the TSS
region within the scope of -3000 to +3000bp. The covplot function was used to calculate the overall
coverage of peaks across the chromosome. Peak annotation was performed using the
“annotatePeak” function that utilizes the mouse annotation database “org.Mm.eg.db”. This would
generate an average profile and heatmap for Peg3 peaks, based on whether the peak belongs to
TSS, Exon, 5’ UTR, 3’ UTR, Intronic or Intergenic. Another function “plotDistToTSS” was used
to calculate the distribution of peak with respect to upstream and downstream from the TSS of the
nearest genes.
Motif identification and discovery
HOMER software was used to compare the consensus motif sequence from the WT sample
peaks to the known motifs database and to find the de novo motifs. It analyzes the genomic position
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to find the enriched motifs. Bed file from the MACS2 output was fed into an executable pearl
script called “findMotifsGenome.pl” within the HOMER. This script sets up the peak bed file for
analysis using the HOMER motif discovery algorithms, which searches for both de novo motif and
enrichment of known motifs. HOMER has two separate approaches for discovering de novo motif
and screening for the enrichment of known motifs. For the former, it takes the input sequences,
parses them into oligos of preferred length, and converts them into a table of oligos. The table then
creates the dataset of oligo based on the occurrence of oligo in both background and target
sequences. HOMER performs a global search to find the enriched "oligos". Afterward, each
enriched oligo is optimized globally before converting them to position-specific probability
matrices. An additional optimization is done using the local optimization method. The enrichment
level is improved repeatedly for these oligos until final motifs are predicted. Whereas, for the latter,
HOMER loads a list of all motifs from the HOMER "known" motif database and JASPAR
database.
Functional enrichment analysis of PEG3 target genes
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were
utilized to examine the functional association of the peaks since they have long-standing
assemblies of updated databases and are accessible for a wide range of organisms. GO is used to
look at molecular activities of genes, the active location of genes, and the processes involving the
activities of these genes. KEGG is a manual compilation of pathway maps obtained through highthroughput experimental genome sequencing (Kanehisa et al., 2017). It shows the molecular
interaction and reaction networks of gene products, which covers seven categories of biochemical
processes, cellular processes, metabolism, organismal systems, genetic and environmental
information processing, drug development, and human diseases. Two separate R packages,
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rGREAT and ChIPseeker were used for the functional study of the enriched peaks. Both packages
are good at predicting the functional enrichment analysis and annotating the Peg3 peaks. rGREAT
was used for annotating peaks to potential biological processes (BP), molecular function (MF),
and cellular components (CC). Alternatively, ChIPseeker was utilized to search the KEGG
databases to look for associated biological pathways.
2.3 Results
Re-analysis of PEG3 binding regions
It is well known that Peg3 belongs to the zinc finger protein family with a KRAB domain,
which is involved in DNA repression activity by forming a complex with SETDB1 (Kim et al.,
1997; Kuroiwa et al., 1996; Urrutia, 2003). In this study, we used already described Peg3 ChIPseq libraries obtained from a homogenous cell population of 14.5 days post coitum MEFs for
extensive analysis (Ye et al., 2016). Four sample files were quality checked before proceeding to
alignment, prediction of peaks (target binding regions), and de novo motif discovery. More details
of the bioinformatic processing of samples files are described in the method section. We utilized
a lenient approach for peak prediction by using a q-value of 0.05 for MACS2 peak prediction,
which is usually used for weaker peaks and to filter out false positives. As described in materials
and methods, we obtained 152 peaks from the WT sample and 163 peaks from the KO sample
(Table A2.2 and Table A2.3). For genome-wide visualization of the peak with respect to
transcription start site (TSS), ngs.plot was utilized. K-means clustering heatmap of the differential
analysis showed usually higher enrichment of Peg3 peaks in TSS region in WT in few of the
clusters. It was, however, scattered all over 3kb upstream and downstream genomic region relative
to the TSS region in KO (Fig 2.1A). Higher peak density around the TSS in WT suggests that Peg3
preferentially binds to the promoter regions and this notion is further supported by the randomly
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scattered nature of peaks observed in KO. Similarly, the meta-profile plot also indicated a similar
result with a higher number of normalized peaks in the center in WT samples (Fig 2.1B). On the
other hand, only seven significant differential peaks were observed between WT and KO using
HOMER software, which is listed on appendix A (Table A2.4). A possible explanation behind this
might be there were only few significantly higher enrichment levels observed in WT samples,
especially where some of the KO samples were not enriched, which might be due to an
experimental error or low quality anti- PEG3 antibody. This potentially inflated the peak height in
KO.

Figure 2.1 Genome-wide differential distribution of peak between samples. (A) Heatmap showing
the enrichment patterns of peaks on the genomic regions that surround the 5kb flanking region of
transcription start sites (TSS) entire gene sets from WT and KO samples. (B) Meta profile
indicating the ChIP-seq enrichment levels between normalized WT and KO samples around TSS
and transcription end site (TES). WT showed a higher level of enrichment in the TSS region when
both normalized WT and KO reads are considered. Indexed Bam files from WT and KO sample
along with their respective input were utilized as inputs for ngs.plot for visualization of peaks at
the functional genomic regions. K-means clustering was used to avoid bias towards largest
coverage reads using the function, ngs.plot.r. The mm10 genome database was used as a reference.
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Global association of PEG3 ChIP-seq peaks
We analyzed the distribution of PEG3-binding sites relative to the nearest genes annotated
in the mouse genome. Firstly, when the absolute distance was considered, the majority of peaks
were within 1kb upstream and downstream of TSS (Fig 2.2A). Secondly, categorization of peaks
per chromosome was also analyzed, which then further showed the almost even distribution of
peaks among the chromosome, except there were only 4 peaks from X-chromosome and 1 peak
from Y-chromosome (Fig 2.2B). Thirdly, peaks were analyzed based on the several categorical
regions in the mouse genome: promoter, 5’ UTR, 3’ UTR, 1st exon, other exons, 1st intron, other
introns, downstream, and distal intergenic region. Our result showed that around 40% of the peaks
mapped close (3 kilobases) to the TSS, followed by about 14% peaks coming from the first intronic
region. Interestingly, there were about 21% peaks located farther than 10kb from the closest TSS,
also known as distal intergenic, which has not been reported before (Fig. 2.1C). Overall, the
presence of majority peaks around the promoter regions suggests PEG3 function in regulating its
downstream genes, whereas distal intergenic peaks might be in the enhancer region that could
indirectly regulate the transcription.
De novo motif analysis
The predicted peak region was analyzed to identify the de novo motif among the Peg3
peaks. PEG3 is a well-known DNA-binding protein with a binding motif of 5’-GTGGCAGT-3’
identified from our lab (S. Lee et al., 2015). In vitro characterization of this motif exhibited a high
level of binding affinity to the PEG3 in the adult mouse brain and demonstrated three G bases and
one T base being vital for its binding activity (S. Lee et al., 2015).
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Figure 2.2 Feature analysis of Peg3 ChIP peaks. (A) Absolute distance of Peg3 peaks to the nearest
TSS. (B) Distribution of Peg3 peaks in terms of their chromosomal positions. (D) Association of
peaks to the promoters, UTRs, exons. Intron or distal intergenic region according to the ChIP data.

In the current study, we used a bioinformatic approach to find the de novo binding motif
using a perl script from HOMER, which extensively searches for both the de novo motif and wellknown motifs. According to the results derived from HOMER analysis, one of the motifs was very
significant with a p-value of 1E-51 and 44 of 152 of the target sequences had that motif. This motif
also had three G bases and one T base in the middle, which matched the previous study done in
the brain sample (Fig 2.3A). In addition, HOMER also compared this novel motif with other
known motifs. Results suggested that there was no overlap with the known motifs, however, one
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motif called ZNF652 was significantly similar to this de novo motif with a p-value of 1E-52.
ZNF652 belongs to the C2H2 zinc finger protein family and functions as a DNA-binding
transcriptional repressor protein (Kumar et al., 2006). Overall, this novel PEG3 motif matched,
with additional modified bases, to the previously characterized motif since it carried the same
critical nucleotides needed for proper binding and showed highly significant similarity to another
zinc finger protein involved in regulating DNA expression.

Figure 2.3 Predicted de novo DNA-binding motif of PEG3 (A) The de novo DNA-binding motif
is shown as a logo as well as presented in a tabulated matrix. (B) Logo converted into a tabulated
matrix based on the occurrence. Perl script from HOMER software was used to predict the novel
motif sequence after several rounds of global and local optimization steps. The p-value of the
predicted motif was 1E-51, which was significant compared to other predicted motifs. The
tabulated matrix had a preferred frequency for each base present in the 12bp long motif.
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Functional analysis of PEG3 Peaks
Gene Ontology (GO) analyses were performed on the direct target genes of the WT sample
obtained from the MAC2 output. R package, rGREAT, was used to predict the potential functional
role of PEG3. First, all the associated biological processes were extracted to derive the significant
processes that Peg3 might be involved in. The top five biological processes mostly included
regulation of the developmental process, transcription, and chromatin organization (Table 2.4).
Table 2.4 Top six Biological Processes (BP) of PEG3. R package, rGREAT, was used for
annotation and functional prediction of peaks.

Second, a potential role in molecular function was examined. Significant functions
included chromatin binding and repressing binding of transcription factors (Table 2.5).
Third, potential cellular components that PEG3 might be involved were predicted.
Unsurprisingly, top cellular complexes like MSL complex, histone deacetylase, and histone
acetyltransferase complexes have already been demonstrated in relation to PEG3 (Table 2.6) (Ye
et al., 2017).
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Table 2.5 Top six molecular functions (MF) of PEG3. Molecular Function (MF) prediction for
the Peg3 peaks was performed using the rGREAT R package.

Table 2.6 Top six predictions of Cellular Component (CC) of PEG3. The prediction was made
using the rGREAT R package

In addition to this, we used another R package, ChIPseeker, to predict the potential
connection of PEG3 to the KEGG pathway. Four of the top five significant pathways were
associated with cancer pathways (Fig 2.4). One of the standout pathways was the Hippo signaling
pathway, which is involed in regulation of cell proliferation and apoptosis as well as has been
associated with breast cancer (Cordenonsi et al., 2011).
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Figure 2.4 KEGG pathway enrichment of Peaks. ChIPseeker was used to annotate the peaks to
their associated pathway. Four of the top five significant pathways were associated with cancer
pathways. About 10% of the genes from ChIP-seq results were predicted from the Hippo signaling
pathway, which is involved in the regulation of cell proliferation and apoptosis.

2.4 Discussion
In the current study, we systematically characterized the ChIP-seq data from MEF cells
using bioinformatic tools. We performed the feature analysis of significant peaks of Peg3,
predicted the de novo motif, and concluded with functional enrichment analysis with several
interesting findings. According to the results, a large percentage of the peak belonged to a
promoter, followed by a distal intergenic region. Motif analysis predicted a similar novel motif
previously reported and comparison with known motif reiterated PEG3 being a zinc finger protein.
Lastly, functional analysis confirmed PEG3 being a transcription repressor and tumor suppressor.
Overall, these results suggest that PEG3 binds the promoter and distant intergenic enhancers and
affects the cellular and molecular functions being a transcription repressor.
First, we chose to re-use the same set of ChIP-Seq results from the previous study, which
only focused on the small number of target genes and subsequent characterization of the H19-ICR
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region (Ye et al., 2016, p. 19). A prominent difference from the previous study is that we performed
a downstream analysis using all the significant ChIP-seq peaks predicted by MACS2. Around 162
peaks were used for feature analysis provided very insightful and interesting results. The majority
of peaks were from promoter regions, which is closely connected with the known functions of
Peg3 as a binding protein for transcription regulation (Fig 2.2) (Frey et al., 2018; Ghimire & Kim,
2021; Ye et al., 2016, 2017). One of the interesting observations was, however, an unusually higher
percentage of distal intergenic peaks. One possible explanation might be that Peg3 being a DNA
binding regulator, binds to these distal regions. These regions are usually enhancers and are
involved in regulating the gene indirectly through enhancers rather than binding directly to a
promoter. Overall, the results described above suggest that PEG3 binds to a promoter or even a
distal intergenic region and regulates the expression of genes indirectly.
Second, the newly predicted de novo motif is comparatively different and longer than the
previously defined motif (Fig 3A). Despite being 12 bases long, as opposed to the previously
reported 8 bases, it still has all the critically defined bases of three Gs and one T in the middle of
the motif (S. Lee et al., 2015). The tabulated matrix, which has a preferred frequency for each base
present in the 12 bp long motif also highlights the importance of few core bases for binding to
target regions (Fig 2.3B). Two factors may be responsible for variation in the orientation and length
of this motif. Firstly, this motif was predicted in MEFs cells rather than the adult brain as in the
previous study (S. Lee et al., 2015). Multiple PEG3 DNA-binding sites might be clustered together
since multiple transcription factor binding sites in DNA are usually distributed in clusters for the
same transcription factors (Gotea et al., 2010). Also, it has been illustrated that the presence of
core nucleotides are enough for binding tightly to the DNA sequence, while the other remaining
bases contribute for non-specific weaker interaction (Iuchi, 2001). The presence of multiple

28

binding sites within a cluster may also contribute to different motifs to recognize a different area
of a cluster (Ezer et al., 2014; Gotea et al., 2010). Overall, this de novo motif may be important in
defining the binding site on its downstream target genes.
Third, GO and KEGG functional analysis confirmed PEG3 as a transcription repressor and
tumor suppressor. When analyzing the influence of Peg3 in the context of the biological process,
the top five processeses were related to the developmental process and negative regulation of
transcription (Table 2.4). This agrees with the previously predicted functional roles of PEG3 in the
developmental process and regulation of transcription (Kuroiwa et al., 1996; L. Li et al., 1999).
Examination of top molecular function suggested PEG3 as binding to the protein, chromatin, and
transcription factors that are involved in repression (Table 2.5). In addition, downstream Peg3
genes were also part of complexes like histone deacetylase, MSL, histone acetyltransferase, and
nucleoplasm (Table 2.6). These associations make sense from the Peg3 perspective since Peg3 is
mainly involved in the transcriptional regulation of several downstream genes and associated with
histone modification through the MSL complex or even ACLY (Ghimire & Kim, 2021; S. Lee et
al., 2015; Thiaville, Huang, et al., 2013; Ye et al., 2016, 2017). KEGG analysis predicted several
cancer pathways, which aligns with its known tumor suppressor role (Fig 4). For example,
hypermethylation of Peg3-DMR is linked with human ovarian and breast cancer patients in which
these patients lose expression of PEG3 (Dowdy et al., 2005; Feng et al., 2008). The most
significant enriched pathway was the Hippo signaling pathway, which is involved in the regulation
of organ growth and tumorigenesis (Yu et al., 2015). It is noteworthy to point out that the Hippo
pathway has already been linked to breast cancer (Cordenonsi et al., 2011). It might not be
speculative to suggest a potential involvement of Peg3 in breast cancer through the Hippo pathway.
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It should be very interesting to investigate these potential connections in the future, which may
provide further insight into possible therapeutic approaches.
Overall, ChIP-seq technology can provide a more efficient and faster approach to identify
key molecular and functional features of a binding protein, which includes discovering de novo
binding motifs as well as cellular and biological process the protein might be involved in. This
study might be useful in identifying such functional aspects of Peg3, which have not been reported
yet. Overall, our work should broaden the existing understanding of the regulatory role of the
PEG3 in controlling transcription.
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CHAPTER III
PEG3 CONTROLS LIPOGENESIS THROUGH ACLY
3.1 Introduction
Epigenetics is an external modification to DNA that affects gene expression without
altering the DNA sequence (Wolffe & Matzke, 1999). Genomic imprinting is an epigenetic
phenomenon in which one allele is expressed while the other one is silenced, depending on its
parental origin. This unusual expression pattern is achieved through DNA methylation and histone
modification (Barlow, 2011; Ivanova & Kelsey, 2011). Around 200 imprinted genes are predicted
to be present in eutherian mammals and believed to be involved in fetal development and animal
behaviors (Keverne, 2013). These imprinted genes are typically clustered in specific chromosomal
regions (Edwards & Ferguson-Smith, 2007). An imprinted domain usually contains 5 to 10 gene
members spanning anywhere from a few hundred kilobases to megabases in length. Imprinted
genes are generally regulated through shared cis-regulatory elements, which are referred to as
imprinting control regions (ICRs) (Wan & Bartolomei, 2008).

Previously Published in PLOS ONE: Ghimire S, Kim J. PEG3 controls lipogenesis through ACLY.
PLoS One. 2021;16: e0252354. doi:10.1371/journal.pone.0252354
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Paternally expressed gene 3 (Peg3) is located on an evolutionarily conserved imprinted
domain on human chromosome 19q13.4/proximal mouse chromosome 7 (Kim et al., 1997). This
conserved imprinted domain spans a 500-kb genomic region and contains six additional imprinted
genes:

paternally

expressed

Usp29 (ubiquitin-specific

hydrolase

29), APeg3 (antisense

Peg3), Zfp264 (zinc finger protein 264) and maternally expressed Zim1 (zinc finger gene,
imprinted 1), Zim2, and Zim3 (He & Kim, 2014). PEG3 protein has a KRAB-A (KruppelAssociated Box A) domain at the N-terminus and C2H2 (Cys2His2)-Kruppel-type zinc finger
domains at the C-terminus. The C2H2 zinc finger domain is responsible for DNA binding, while
the KRAB-A domain is responsible for the physical interaction and subsequent recruitment of
another protein called KAP1 (Kruppel-Associated Protein 1) (He, Ye, et al., 2016). KAP1 is a
well-known corepressor that interacts with several epigenetic modification proteins, including
SETDB1 (histone 3 lysine 9 methyltransferase) and DNMT3A (DNA methyltransferase 3A)
(Friedman et al., 1996). The Peg3 domain has a 4-kb Peg3-DMR (differentially methylated
region), which functions as an ICR (Kim et al., 2003). This ICR is the most critical for controlling
the transcription and imprinting of the Peg3 domain (Kim et al., 2003; Kuroiwa et al., 1996).
Deletion of this ICR results in global change in the transcriptional levels and also causes the
biallelic expression of several adjacent imprinted genes (Kim et al., 2012; Ye et al., 2016). Another
study revealed that an alternative promoter, U1, localized 20-kb upstream of Peg3-DMR, is known
to establish DNA methylation on the maternal allele of Peg3-DMR during oogenesis (Perera &
Kim, 2016). Deletion of the U1 promoter results in a loss of allele-specific methylation of Peg3DMR, causing the biallelic expression or double dosage of Peg3 and Usp29 (Perera & Kim, 2016).
ATP-citrate lyase (ACLY) is a 121-kDa cytosolic enzyme that catalyzes mitochondriaderived citrate and coenzyme A into acetyl-coenzyme A (acetyl-CoA) and oxaloacetate (OAA) by
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hydrolyzing ATP (Watson et al., 1969). ACLY is known to link glucose metabolism to the fatty
acid (FA) and the cholesterol synthesis pathways. Cytosolic acetyl-CoA is a building block for the
following lipid biosynthetic pathways. First, through fatty acid synthesis, acetyl-CoA is converted
to triglyceride for the storage of fat within cytoplasmic lipid droplets. Second, through
cholesterogenesis, acetyl-CoA leads to the synthesis of cholesterol and isoprenoids (Hatzivassiliou
et al., 2005). ACLY is overexpressed in several tumors (Migita et al., 2008; Turyn et al., 2003;
Varis et al., 2002; Yancy et al., 2007). In one of the studies, ACLY production was found to be
significantly higher by more than 160-fold in breast carcinoma (Szutowicz et al., 1979).
Additionally, one of the hallmarks of the tumor is higher levels of de novo FA biosynthesis as a
result of a significant increase in the expression and activity of several enzymes involved in the
FA synthesis pathway (Mashima et al., 2009). Fatty-acid synthase (FASN), which is involved in
de novo FA synthesis, is also found to be overexpressed in numerous cancers, including breast,
lung, stomach, ovary, colon, and prostate cancers (Kuhajda, 2000). Furthermore, isocitrate
dehydrogenase 1 (IDH1), which catalyzes the reverse reaction of converting α-ketoglutarate to
isocitrate in the cytoplasm for the synthesis of body fat and lipids, is responsible for de novo
lipogenesis and is a major NADPH producer (Chu et al., 2015; D’Adamo & Haft, 1965; Metallo
et al., 2012). Lastly, several tumors also show an increase in the amount of the enzyme, 3-hydroxy3-methylglutaryl-CoA reductase (HMGCR), or a lack of feedback mechanism for HMGCR in the
mevalonate (cholesterol synthesis) pathway (Larsson, 1996).
A previous study involving genome-wide expression analyses revealed that the lipid
metabolism is affected in the mutant model of Peg3 (Kim et al., 2013). Another study has shown
that Peg3 mutant mice had an excess of abdominal, subcutaneous, and intra-scapular fat even in
low food intake (Curley et al., 2005). While this would suggest that Peg3 may be responsible for
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the regulation of fat metabolism, there are still knowledge gaps in terms of how this might be
accomplished. In the current study, we identified Acly, Idh1, Fasn, and Hmgcr as potential
downstream genes from ChIP-seq analysis. According to the results, the promoter of these genes
is bound by Peg3 and the variable dosages of Peg3 affect the expression levels of these genes.
This suggests that PEG3 may play a role in regulating the lipogenesis pathway via ACLY.
3.2 Materials and Methods
Ethics statement
All the experiments related to mice have been conducted in conformance with the National
Institutes of Health guidelines for the care and use of animals. Furthermore, these experiments
were also assisted by Louisiana State University Institutional Animal Care and Use Committee
(IACUC), protocol 19–079.
Mouse Breeding
The mice used for this experiment were C57BL/6J strain housed on a 12–12 dark-light
cycle under a constant temperature of 70°F and 50% humidity at the DLAM (Division of Lab
Animal Medicine) at LSU. Two mutant strains of Peg3 were used, which have been previously
characterized: the CoKO strain with the modification within its 5th intron of Peg3 and the U1
strain with the 1-kb deletion of the alternative U1 promoter (Bretz & Kim, 2017; Kim et al., 2013).
All the mice were euthanized by CO2 asphyxiation under the rules and regulations set forth by the
IACUC. Breeding experiments were performed through the crossing of males Peg3CoKO/+ with WT
females and females Peg3U1/+ with WT males. For the embryos, individual embryos were isolated
along with placentas from pregnant females. The latter was used for genotyping and sex
determination of the associated embryo. Embryos were then snap-frozen in liquid nitrogen for
future experiments. Likewise, adult mice were also genotyped by using genomic DNA obtained
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from clipped ears. These tissues were incubated in lysis buffer (0.1 M Tris-Cl, pH 8.8, 5 mM
EDTA, pH 8.0, 0.2% SDS, 0.2 M NaCl, 20 μg/ml Proteinase K) overnight at 55⁰C. For genotyping,
the following set of primers were utilized: for the CoKO allele, Peg3-5arm (5′CCCTCAGCAGAGCTGTTTCCTGCC-3′) and LAR3 (5′-CAACGGGTTCTTCTGTTAGTCC3′);

for

the

U1

allele,

P1

GGAAGCCTCCATCCGTTTGT-3’),

(5’-TAGCAAGGGAGAGGGCCTAG-3’),
and

P3

P2

(5’-

(5’-AGCACAGCTAGAAATACACAGA-

3’). Coupled with physical appearance, the sex of each pup was also determined via PCR using a
forward and reverse set of primers: mSry-F (5’-GTCCCGTGGTGAGAGGCACAAG-3’) and
mSry-R (5’-GCAGCTCTACTCCAGTCTTGCC-3’).
RT-qPCR
Trizol isolation kit (Invitrogen) was used to isolate total RNA from the extracted tissues,
either embryo or adult mammary gland of mice. Random hexamer was added to the isolated RNA
(1 ug), which was then followed by the addition of M-MuLV reverse transcriptase (New England
Cat. No. M0253S). For each gene tested, cDNA was used as a template for quantitative PCR. The
SsoAdvancedTM Universal SYBR Green Supermix (Bio-Rad) was used for qRT-PCR analysis
using the ViiATM 7 Real-Time PCR system (Life Technologies). All qRT-PCR analyses were
conducted for 40 cycles under standard PCR conditions. Expression levels of the genes were
normalized to internal control, Gapdh, and analyzed further based on the threshold (Ct) value. The
Ct value of a technical replicate of a particular gene was subtracted from the average Ct value of
the internal control (Gapdh) for that gene to calculate the Ct value. The fold difference was
calculated for each replicate by raising 2 to the Ct powers (Winer et al., 1999). The average and
standard deviation of fold differences of each sample were then plotted. For statistical comparison,
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a one-tailed Student’s t-test was used on the samples. More detailed information on each of the
primer sequences is available below (Table 3.1)
Table 3.1 Primer sets used for RT-PCR and qRT-PCR experiments.
RT-Primers
Oligo Sequence
Peg3-RT-F

GGTTCAGTGTGGGTGCACTAGACT

Peg3-RT-R

TCCCTAGTGTGCATGATCTGGT

Hmgcr-RT-F

ACAGGCCGGGAAGAATGTC

Hmgcr-RT-R

GACCTTTCTAGAGCGAGTGCA

Idh1-RT-F

CCTGAGCTAATTTGGCCTTCA

Idh1-RT-R

CATGTACCAGAAAGGGCAAGA

Fasn-RT-F

GATGACAGGAGATGGAAGGCTG

Fasn-RT-R

TCGGATGCCTCTGAACCACTCA

Acly-RT-F

GGCTGGAGCGATCCGAAGAG

Acly-RT-R

CACGGGTGGTCCTGCAGCA

Gapdh-RT-F

ATGACATCAAGAAGGTGGTG

Gapdh-RT-R

CATACCAGGAAATGAGCTTG

ChIP and ChIP-seq Analyses
Chromatins were prepared from MEFs and neonatal brains according to the methods
previously described (Kim et al., 2003). Briefly, one percent formaldehyde was used to crosslink
homogenized cell samples and then lysed with the lysis buffer containing protease inhibitor
cocktail (Millipore, Cat. No. 539131). The lysed sample was sonicated to derive 300 to 500 bp
sizes of DNA fragments, which were then immunoprecipitated against the commercial polyclonal
anti-PEG3 antibody (Abcam, Cat. No. ab99252). Protein A/G PLUS-Agarose beads (Santa Cruz,
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Cat. No. sd-2003) were used to pull down the protein complexes. Finally, the isolated protein
complexes were de-crosslinked and treated with phenol-chloroform. The purified DNA was
dissolved in 100 ul of TE buffer for later use. For ChIP-seq analysis, two different samples of MEF
cells (WT and CoKO) were used. A combination of these two samples with the corresponding
input DNA were utilized for the ChIP-seq library construction following the manufacturer's
protocol (Illumina FC4014003). Bowtie2 was used to map all of the initial raw sequences, which
were around 35 million reads per sample, to the mouse genome sequence (Langmead et al., 2009).
Next, we processed the sam files obtained from mapping with Bowtie2 to the bigwig files. Bigwig
files were uploaded to the UCSC genome browser for peak visualization. A gene list was created
by manually inspecting the ChIP-seq peaks with a minimum threshold p-value of 10 throughout
the mouse genome. The obtained gene list was used for pathway analyses using the Kegg pathway
database (https://www.kegg.jp/kegg/). Overlapped sets of genes between the identified genes from
ChIP-seq

data

and

various

pathways

were

identified

using

Venny

software

(https://bioinfogp.cnb.csic.es/tools/venny/). The file containing the list of the downstream genes
of Peg3 in each of the 30 KEGG metabolic pathway that were derived from ChIP-seq dataset is
available

to

download

from

the

following

link

provided

below,

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162686/bin/pone.0252354.s005.xlsx .
3.3 Results
Variable gene dosages of Peg3 (0x, 1x, and 2x)
For the current study, we used the following two mutant alleles with variable dosages of Peg3
(Kim et al., 2013; Ye et al., 2014). The first mutant allele is referred to as CoKO (Conditional
KnockOut-ready). This model was constructed to truncate transcription of Peg3 by inserting two
poly(A) signals as a part of an expression cassette containing a promoterless β-galactosidase
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gene and the neomycin resistance gene driven by the human β-actin promoter within the 5th
intron of Peg3 (Figure 3.1A) (Kim et al., 2013). With the paternal transmission (+/-P), the gene
dosage of Peg3 is almost zero in heterozygous individuals, thus the 0x dosage of Peg3.
Conversely, with the maternal transmission (-M/+), the dosage is similar to the WT, the 1x
dosage of Peg3, because it is already silenced by DNA methylation (Kim et al., 2013).
Table 3.2 Primer sets used for ChIP experiments
RT-Primers

Oligo Sequence

mAcly-chip-F

GGACGCGCAAAGGCAATCCGGA

mAcly-chip-R

GTACCCACTAAGCTTCCTGCTTC

mIdh1-chip-F

CTGGGTTGCGATGAAGCTGCACT

mIdh1-chip-R

CACATAGCGCCCTCTAGCGTCCA

mFasn-chip-F

CTCGGCCTGATCGCGGAGCTCA

mFasn-chip-R

AATAGCGCCGGCGCGGCCTAGA

mHmgcr-chip-F

CAGGCACTCGTACACGGATG

mHmgcr-chip-R

CTAGGGGATCGGACGATCCT

The second mutant allele is U1 (2x Peg3 dosage), which has a 1-kb deletion of the genomic
region containing an alternative U1 promoter located 20-kb upstream of the Peg3-DMR region
(Figure 3.1B). Deletion of the U1 promoter results in the biallelic expression of Peg3 and Usp29
due to the absence of oocyte-driven DNA methylation on the Peg3-DMR (Perera & Kim, 2016).
With the maternal transmission of the U1 allele, the gene dosage of Peg3 is almost double in F1
heterozygote, thus the 2x dosage of Peg3 (Bretz et al., 2018). On the other hand, with the paternal
transmission, there is no difference in the gene dosages of Peg3 compared to WT. For the current
study, we performed the following set of breeding experiments to harvest the tissues with variable
dosages of Peg3. For the 0x dosage of Peg3, WT females were crossed with males heterozygous
for Peg3CoKO/+ to achieve the paternal transmission of the CoKO allele. We harvested two
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biological replicates of 14.5-dpc (days post-coitum) embryos of each sex with WT and CoKO
genotypes. Likewise, the mammary gland was extracted from two 1.5-month-old virgin adults of
each sex with WT and CoKO. For the 2x dosage of Peg3, WT males were crossed with females
heterozygous for Peg3U1/+. Similar to CoKO breeding, we harvested two biological sets of 14.5dpc embryos and 1.5-month old individuals of both sexes with WT and U1 genotypes, from which
the mammary gland was harvested.

Figure 3.1 Genomic structure of CoKO and U1 mutant alleles of the Peg3 locus. (A) Schematic
representation of WT and CoKO allele of the mouse Peg3 locus. Exons of Peg3 are indicated with
blue boxes. The 7.1-kb insertion cassette contains promoterless galactosidase (β-Gal) and human
β-actin promoter-driven neomycin resistance gene (NeoR), which are indicated with white boxes.
The Poly(A) tails associated with these genes are indicated with grey boxes. This expression
cassette is flanked by brown oval-shaped FRT boxes. The Poly(A) tails are accountable for the
truncation of Peg3 expression, thus the 0x dosage of Peg3. (B) Schematic representation of WT
and U1 alleles. The blue color indicates the genes associated with the paternal allele and the orange
color represents the genes associated with the maternal allele. Maternal deletion of an alternative
promoter, U1, causes the expression of Peg3 and Usp29 from the maternal allele, subsequently
responsible for the expression levels of 2x dosage of Peg3.
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Genome-wide scanning and pathway analysis of Peg3 downstream genes
We analyzed ChIP-seq results, which were derived from mouse embryonic fibroblast cells
(MEFs) from WT and CoKO samples (Kim et al., 2013). Raw sequence reads were analyzed using
the bioinformatic pipeline involving a peak prediction program, MACS2 (Y. Zhang et al., 2008).
This program identified around 16 downstream genes of Peg3 with a significantly high average pvalue being around 25 (Ye et al., 2016). However, MACS2 only predicted a very small number of
peaks due to its highly stringent peak selection parameters. We further extended this analysis by
manually scanning the ChIP-seq peaks across the whole mouse genome. We identified peaks with
a minimum threshold p-value of 10 but with no peak on the Peg3 mutant (CoKO) samples, which
were used to filter background noise. A total set of 1073 genes were identified from this analysis.
The majority of the peaks were overlapped with the promoter regions of the individual genes. We
then performed pathway analysis, which revealed that some pathways have a greater number of
downstream targets of Peg3 than the other pathways. Interestingly, most of these are well-studied
pathways: cancer pathway (32 out of 328 genes), p53 signaling pathway (8 out of 69 genes),
MAPK signaling pathway (21 out of 267 genes), WNT signaling pathway (12 out of 151 genes),
and Jak-STAT signaling pathway (9 out of 155 genes) analysis (Figure 3.2). These results go along
with the previous Peg3 studies revealing its connection to cancer, p53, Wnt, and Jak-STAT
pathways (Deng & Wu, 2000; Feng et al., 2008; Jiang et al., 2010; Makowska et al., 2012).
Peg3 is also known to be closely associated with several metabolic pathways, including
lipid metabolism based on the mutant phenotypes of Peg3 (Bretz et al., 2018; Curley et al., 2005;
Kim et al., 2013). Thus, we further examined whether there is an overlap between these potential
downstream genes of Peg3 and the genes involved in the metabolic pathway. Around 171
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downstream genes were found to be overlapped out of the total set of 1073 genes when we
analyzed more than 30 key metabolic pathways.

Figure 3.2 List of pathways with potential downstream genes of Peg3. Thirty pathways were
examined to find the overlapping genes between the gene list containing the downstream gene of
Peg3 and the given pathway using KEGG pathway.

Among the predicted metabolic pathways, the lipogenesis pathway was of particular
interest based on the following reasons. Several key genes critical for the lipogenesis were found
to be potential downstream genes of Peg3: Acly (ATP-citrate lyase), Fasn (Fatty-acid synthase),
Idh1 (isocitrate dehydrogenase 1), and Hmgcr (3-hydroxy-3-methylglutaryl-CoA reductase). In
particular, these genes are also positioned at the entry point of each synthesis pathway (Figure 3.3).
ACLY links the glycolysis and TCA cycle to the fatty acid and the cholesterol synthesis pathway
by providing acetyl-CoA (Hatzivassiliou et al., 2005). Similarly, IDH1 mediates reductive
carboxylation of α-ketoglutarate to isocitrate for the synthesis of lipids. Overexpression of Idh1 is
associated with an increase in body weight, fat mass, serum cholesterol, and triacylglycerols (Koh
41

et al., 2004). FASN is a key enzyme in the fatty acid synthesis pathways, β-oxidation, and lipid
modification of cellular proteins (Mashima et al., 2009). Lastly, HMGCR is a critical enzyme
involved in the first and rate-limiting step in the mevalonate pathway. Inhibition of HMGCR in
normal cells triggers a robust homeostatic feedback response that ensures the cells to upregulate
and restore the mevalonate pathway (Davidson, 2001). Given the close connection of Peg3 to
lipogenesis, we further analyzed these four genes as described below.

Figure 3.3 Peg3 downstream genes involved in major metabolic pathways. The schematic figure
shows the combination of several metabolic pathways from glycolysis to lipogenesis (fatty acid
synthesis and mevalonate pathway). Glucose-derived citrate is converted to acetyl-CoA by ATPcitrate lyase (ACLY), which is used as a precursor in fatty acid and the mevalonate synthesis
pathways. This current study identified 1073 genes as the downstream genes of Peg3 from
genome-wide scanning of ChIP-seq peaks. More than 30 pathways were examined to test if there
were any overlapping genes between these pathways and the genes identified from ChIP-seq
analysis using the Kegg pathway database (https://www.kegg.jp/kegg/). Initial analysis identified
several key genes critical for lipogenesis, including Acly, Idh1, Fasn, and Hmgcr.
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In vivo binding of PEG3 to the genes involved in lipogenesis
The potential downstream genes of Peg3 involved in lipogenesis were further confirmed
by individual ChIP experiments. Two sets of chromatins were prepared from MEF cells and
neonatal brains with each set representing WT and CoKO samples. Each ChIP derived three
individual DNA: Input, Negative control (Neg), and the immunoprecipitated DNA with anti-PEG3
antibody (PEG3 IP). Individual immunoprecipitated DNA was analyzed with a fixed number of
PCR cycles (38 cycles) as well as a quantitative PCR (Figure 3.4). Four individual primer sets
were designed and used to target the promoter regions of the potential downstream genes. In the
case of Acly, this analysis showed the detectable levels of enrichment in WT MEF but no
enrichment levels in CoKO MEF, confirming the in vivo binding of PEG3 to the promoter of Acly
(Figure 3.4B). Results from qPCR also corroborated this result as the enrichment levels were
almost 5-folds higher than those of CoKO MEF (Figure 3.4C). However, no detectable levels of
the enrichment of DNA were observed for both WT and CoKO in the brain (Figure 3.4B). We
were also able to confirm the binding of PEG3 to Idh1 in both the MEF cells and the brain (Figure
A3.1). Furthermore, we confirmed the in vivo binding of PEG3 to Hmgcr and Fasn in the MEF
cells but not on the brain (Figure A3.2 and A3.3). Overall, this series of analyses confirm the
binding of PEG3 to Acly, Fasn, and Hmgcr in MEF and Idh1 in both MEF and neonatal brain.
Expression level changes of Acly in response to the variable dosages of Peg3
To examine the functional outcomes of different dosages of Peg3 on the expression levels
of Acly, a series of qRT-PCR was performed. According to the previous studies, higher expression
levels of Peg3 were observed in embryos, placenta, hypothalamus, and mammary gland (Kim et
al., 1997). Thus, we chose embryos as the first target tissue. Also, among these tissues, the
mammary gland was noteworthy for the following two reasons. Firstly, the mutant phenotypes of
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Peg3 are associated with a defect in milk provision and involve the mammary gland (Frey & Kim,
2015; Gimpl & Fahrenholz, 2001). Secondly, the mammary gland produces milk that has a high
percentage of fatty acid globules (Jensen, 1999). These reasons prompted us to pursue the
mammary gland as the second target tissue for the following examinations.

Figure 3.4 In vivo binding of PEG3 to the promoter of Acly. (A) ChIP-seq results from the 80-kb
genomic intervals encompassing Acly. The top panel is from WT-MEF cells and the bottom panel
is from KO-MEF cells. Statistical p-values are indicated on the Y-axis with the maximum value
being 10, whereas relative genomic positions are on the X-axis. An arrow represents the
transcriptional direction of Acly. (B) Individual ChIP experiment confirming the in vivo binding
of PEG3 to the promoter regions of Acly. Chromatins were prepared from the 14.5-dpc embryos
and neonatal brains of WT and CoKO. The template for PCR reaction was the immunoprecipitated
DNA either from WT or KO-MEF cells with the anti-PEG3 antibody. In addition, the Input and
Negative (Neg) DNA was also included in this PCR amplification. The Neg control contained the
DNA from the ChIP experiment without the antibody. (C) Quantitative PCR results from the
immunoprecipitated DNA with the anti-PEG3 antibody. The red and blue bars indicate the relative
enrichment levels of PEG3 IP and Neg compared to the Input in the promoter regions of Acly.
Relative enrichment values are indicated on the Y-axis for each sample. All the analyses were
performed in triplicates. The statistical significance of the observed difference between PEG3 IP
and Neg was tested with a student t-test (*, p-value <0.05 and ***, p-value <0.0001).
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We examined two biological replicates of 14.5-dpc embryos and the mammary gland of
1.5-month-old adult virgin mice of each sex. F1 and F2 represent two biological female samples,
whereas M1 and M2 represent two biological male samples. The total RNA was isolated from
these samples, used for cDNA synthesis, and finally analyzed with qRT-PCR. The expression
levels were compared among the WT (1x), CoKO (0x), and U1 (2x) samples. Gapdh was used to
normalize the expression levels of each gene before comparing WT and U1/CoKO. The results are
summarized as follows. First, for 14.5-dpc embryo samples, the expression levels in CoKO
increased by about 1.4-fold in 3 out of 4 embryos. These observed upregulations were statistically
significant with the p-value being lower than 0.03 (Figure 3.5A). In the case of U1 samples,
however, there was an opposite effect, with U1 showing about a 30% decrease in the expression
levels of Acly in embryos, with 2 out of 4 samples being statistically significant (p=0.02; Figure
3.5B). Second, for adult mammary glands, the expression levels of Acly in both female CoKO
samples were around 2-fold higher than WT samples, whereas the levels in male CoKO samples
were lower by 60% than WT samples, showing sex-specific up and down-regulation in females
and males respectively (p=0.004-1; Figure 3.5C). In contrast, for U1 samples, there was a 1.2-2.1fold increase in the expression levels of Acly in both female and male adult mammary glands
(p=0.02-0.09; Figure 3.5D). Overall, this series of expression analyses provides two immediate
conclusions. First, in embryos, Acly responded oppositely against Peg3 dosage, which is consistent
with the predicted function of Peg3 as a repressor (S. Lee et al., 2015; Thiaville, Huang, et al.,
2013; Ye et al., 2016). Second, sex-biased results were observed, especially in the adult mammary
gland, as the expression levels of Acly was up in female but down in male, albeit, only in CoKO
samples.
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Figure 3.5 Expression level changes of Acly against the 0x and 2x dosage of Peg3. Expression
levels of Acly were measured using a series of qRT-PCR. This set of analyses was performed using
two biological replicates for both the embryo and the mammary gland set of males (M1 and M2)
and females (F1 and F2). The total RNA was isolated from the embryos and the mammary glands
with WT (1x), CoKO (0x), and U1 (2x) dosage of Peg3. The expression level differences in the
14.5-dpc embryos were summarized in the first column (A, B) and the adult mammary glands in
the second column (C, D). Individual gene expression levels were first normalized to Gapdh levels
and then normalized values were further compared between WT and the mutants (CoKO or U1).
Subsequent relative levels are presented in a graph with the average values and standard deviations.
The statistical significance of the observed difference between WT and mutants was tested with a
student t-test (*, p-value <0.05 and ***, p-value <0.0001). The corresponding p-values are listed
in the text.

Expression level changes of the downstream genes in the adult mammary gland
We performed another series of expression analyses with a set of additional downstream
genes, Fasn, Idh1, and Hmgcr. A similar series of qRT-PCR analyses were performed using total
RNA isolated from the adult mammary gland as described above. The results are summarized as
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follows. First, for Fasn, the expression levels in the CoKO females were about 3.5-fold greater
than WT samples, whereas the expression levels in the CoKO males were 70% lower than WT
(p<0.003; Figure 3.6A). In the case of U1 samples, there were no significant changes except the
U1-M1 sample, which showed a 60% decrease in expression levels (p=0.01-0.9; Figure 3.6B).

Figure 3.6 Expression level changes of Fasn, Idh1, and Hmgcr. A series of qPCR assays were
performed to measure the expression levels of Fasn, Idh1, and Hmgcr between WT and CoKO/U1.
For these analyses, two males (M1 and M2) and two females (F1 and F2) were used. Total RNA
was isolated from the adult mammary glands, which was subjected to cDNA synthesis. A qRTPCR was then performed. Gapdh was used to normalize the expression levels of each gene before
comparing WT and U1/CoKO. The results sets were summarized with the average values and
standard deviations. The statistical significance is indicated in the following student’s t-test (*, pvalue <0.05 and ***, p-value <0.0001). The corresponding p-values are listed in the text.

47

Second, regarding Idh1, there was about a 1.5-2.9-fold increase in expression levels in the
CoKO females whereas expression levels significantly decreased by around 60% in CoKO male
samples (p=0.006-0.39; Figure 3.6C). However, for the U1 sample, there was a decrease in
expression levels in both sexes except the U1-F1 sample (p=0.04-0.9; Figure 3.5D). The observed
expression levels of both Fasn and Idh1 were similar to the pattern seen in Acly, showing sexspecific up and down-regulation of expression levels in the females and the males of CoKO
respectively. Finally, for Hmgcr, the expression levels were 1.4-2.1-fold higher in CoKO females
(p=0.0059-0.66). Results from male CoKO samples, nonetheless, were inconclusive as two
biological samples portrayed contrasting expression levels (Figure 3.6E). Unlike CoKO, the
expression levels of the U1 samples decreased in females (p=0.004-0.2) and were similarly
inconclusive in males (Figure 3.6F). It is prudent to mention that the variations were observed in
the expression levels among the biological replicates. This might have been due to unknown
variations in tissue samples, individual mice, and litter numbers. Together, these results indicate
sex-specific responses of Fasn and Idh1, especially in CoKO samples, but little or no responses in
U1 samples.
3.4 Discussion
In this study, we characterized four downstream genes of Peg3 involved in lipogenesis:
Acly, Idh1, Hmgcr, and Fasn, which were identified through analyzing previous ChIP-seq data
(Ye et al., 2016). Through individual ChIP experiments, we further confirmed the in vivo binding
of PEG3 to the promoter regions of Acly, Fasn, Idh1, and Hmgcr. Expression analyses using two
mutant mouse models, CoKO (0x Peg3) and U1 (2x Peg3), demonstrated the opposite response of
Acly expression levels against the dosage of Peg3 in embryos, suggesting Peg3 as a transcriptional
repressor for the expression levels of Acly. On the other hand, the analyses using the mammary
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gland showed a sex-specific opposite response of the expression levels of Acly, Fasn, and Idh1
against 0x Peg3, with higher levels in females and lower levels in males as compared to the
wildtypes (Figure 3.5 and 3.6). Overall, this study suggests that Peg3 is involved in regulating the
expression levels of key genes in adipogenesis.
Peg3 appears to be a DNA-binding regulator for Acly as Peg3 is shown to bind to the
promoter region of Acly (Figure 3.4). The Peg3 dosages also affected the expression levels of Acly
in embryos (Figure 3.4 and 3.5AB). These results comply with the previous studies showing the
DNA-binding capability of PEG3 and controlling the expression levels of several downstream
genes, including Oxtr, H19, Msl1, and Msl3 (Frey et al., 2018; Thiaville, Huang, et al., 2013; Ye
et al., 2016, 2017). In the mammary gland, Peg3 dosage appeared to be associated with the
expression level of the key gene, Acly, connecting the glucose metabolism and lipid synthesis
(Figure 3.7). It has already been shown that the loss-of-function mutation on Peg3 contributes mice
to have a smaller body size but with a higher proportion of adipocytes than the wildtypes and the
upregulation of the genes involved in lipid metabolism (Curley et al., 2005; Kim et al., 2013).
Moreover, epigenetic silencing of PEG3 is frequently associated with several cancers, suggesting
a tumor suppression function of PEG3. One study also reported the reduced expressions of PEG3
in 18 different types of cancers in humans (M. Li et al., 2017). Additionally, the loss of PEG3
expression is connected to ovarian, breast, and cervical cancer (Feng et al., 2008; Nye et al., 2013;
M. Zhang & Zhang, 2020). Furthermore, a significant upregulation of ACLY expression has been
associated with several tumors, including lung, prostate, bladder, breast, liver, stomach, and colon
tumors (Migita et al., 2008; Turyn et al., 2003; Varis et al., 2002; Yancy et al., 2007). Interestingly,
tumor progression is associated with an increase in lipid synthesis, and thus ACLY tends to be
overexpressed in such cancer cells to accelerate lipid synthesis and tumor progression (C. Zhang
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et al., 2016). ACLY has already been identified as a potential molecular target for cancer therapy,
as de novo fatty acid synthesis occurs at very high rates in tumor tissues (Hatzivassiliou et al.,
2005). This aligns with our finding that the silencing of PEG3 might upregulate the expression
levels of ACLY, which might be required for the high demand of lipids for the rapidly dividing
cancer cells. Overall, this suggests that Peg3 is the upstream regulator of Acly by binding to the
promoter and affecting the expression levels of Acly.

Figure 3.7 Peg3’s potential control on lipogenesis through Acly. Schematic representation of the
potential downstream genes of Peg3 and their associated metabolic and lipogenesis pathways. Red
color genes, Fasn, Idh1, and Hmgcr, are potential downstream genes predicted from the ChIP-seq
analysis. All of these genes are involved in either regulating Acly or fatty acid and mevalonate
pathways. With the variable dosages of Peg3, changes were observed in the expression levels of
these genes, which are indicated with vertical arrows. Yellow arrows indicate 0x dosage of Peg3
and green arrows represent the 2x dosages of Peg3. Sex-specific response in the expression levels
of Acly, Fasn, and Idh1 in the adult mammary gland was also observed in CoKO (0x Peg3). This
suggests that Peg3 may play a role in lipogenesis by regulating the expression levels of Acly and
several key genes.
50

We observed a sex-specific opposite response in the expression levels of Acly, Idh1, and
Fasn in the adult mammary gland in CoKO (0x Peg3), showing upregulation in females and
downregulation in males as compared to those of WT littermates (Figure 3.5 and 3.6). It has
already been shown that Peg3 and Acly are sexually dimorphic in their expression levels
(Fernandez et al., 2019; He, Perera, et al., 2016). Therefore, the expression levels of Peg3 may be
regulated by sex-specific hormones. Consistent with this, our meta-analysis revealed that one of
the potential enhancers of Peg3, ECR17 (Evolutionarily Conserved Region), has a binding site for
the male-specific sex hormone, androgen (Kim et al., 2019). Similarly, the mammary gland, our
tissue of interest, is fully developed in females during puberty in response to the release of
estrogen, which itself is a sex-specific hormone (Behl & Holsboer, 1999; Macias & Hinck, 2012).
Therefore, lipid and glucose metabolisms in the mammary gland are likely sex-specific processes
(Varlamov et al., 2015). It is also important to note that the sex-specific response was only
observed in the mammary glands but not in the embryos. This discrepancy can be explained by
the fact that the mammary gland is a highly differentiated and specialized tissue with specific
functions, whereas the embryo comprises the whole body. All these factors combined might have
contributed to the sex-specific results as different sexes were behaving differently to the dosages
of Peg3, in particular 0x dosage of Peg3.
Reduced gene dosage of Peg3, 0x Peg3 (CoKO), appears to contribute more significant
fluctuation to the expression levels of Acly, Fasn, and Idh1 compared to double dosage of Peg3,
2x Peg3 (U1) in mammary glands (Figure 3.5 and 3.6). We expect two possibilities that might
contribute to the discrepancy. First, ACLY is a very critical enzyme, which provides acetyl groups
for histone acetylation/gene regulation and lipid synthesis. Thus, several additional genes or
regulatory factors may regulate the expression of Acly (Favara et al., 2019; Han et al., 2020). By
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contrast, Peg3’s role in the regulation of Acly expression might be minimal or indirect. This might
be a reason for the observed discrepancy. Second, Acly, Fasn, and Idh1 are the major genes for
metabolic pathways and their expression levels are, in general, already high in the cells and also
critical for the survival of organisms (Sivanand et al., 2017; Wellen et al., 2009; Zaidi et al., 2012).
As a result, the expression levels of these genes may be tolerable only in one of the two mutant
models; the upregulation may be tolerable in CoKO, whereas the downregulation may be
intolerable in U1. As a consequence, we might be able to observe the upregulation from the
surviving CoKO model, but not from the downregulation from the U1 model. The second scenario
seems more plausible since our results showed these genes to be immediate downstream targets of
Peg3 with individual ChIP experiments demonstrating the in vivo binding of PEG3 to the promoter
regions of Acly and Idh1.
Lastly, our result showed some degrees of individual variation for both male and female
samples. We repeated the expression level analyses several times to minimize the human error as
well as to increase the confidence in the results. Since we are dealing with the enzymes and the
tissues that are highly modulated mainly through hormonal response, the multitude of subtle
factors that could potentially affect the outcome cannot be discredited. However, considering all
the hormonal, metabolic, and litter number variations, our results look promising as there is a
possible role of PEG3 in adipogenesis via ACLY when the individual is subjected to PEG3 dosage
variation. This might also open the possibility for potential drug design for the tumors involving
defective ACLY by targeting PEG3.
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CHAPTER IV
SUMMARY AND FUTURE DIRECTIONS
Imprinted genes play critical roles in regulating the growth and development, cellular
processes, and behaviors of an organism (Barlow & Bartolomei, 2014; Keverne, 2015). Two or
more imprinted genes are generally distributed as a cluster in specific regions of chromosomes
(Barlow, 2011). One such domain is the Peg3 domain, which has 7 imprinted genes clustered
together within a 500kb genomic region and is involved in several downstream functions. This
dissertation presents the data illustrating the functional role of Peg3. First, it characterizes the
genome-wide features of ChIP-seq peaks and redefines the binding motif of PEG3 target
sequences. Second, it elucidates several downstream novel biological processes and pathways as
well as the role of PEG3 in regulating the lipogenesis pathway.
Our lab mainly focuses on characterizing Peg3 and its potential functional impact on the
gene expression of its downstream genes using the mouse model. The binding mechanism of PEG3
and its binding motif have been well characterized by our group (He, Ye, et al., 2016; S. Lee et al.,
2015; Thiaville, Huang, et al., 2013). The functional role of PEG3 as a repressor has also been
demonstrated utilizing several downstream genes, including the transcription of H19, Msl, and
Oxtr (Frey et al., 2018; He, Ye, et al., 2016; Ye et al., 2016, 2017). In 2013, a genome-wide
expression study of Peg3 mutant mice exhibited that many genes involved in lipid metabolism and
placenta-specific gene families were noticeably affected (Kim et al., 2013). These interesting
results provided an incentive to examine the functional effect of PEG3 more systematically and
identify potential novel motifs. We performed ChIP-seq analysis using mouse embryonic
fibroblast (MEF) cells. MEF cells were extracted from 14.5 dpc embryos from the same littermates
of wildtype (WT) and Peg3-knockout (KO) mouse in 2015 (Ye et al., 2016, p. 19). This culminated
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to this project, which analyzed the ChIP-seq systematically using both bioinformatics tools and
manually to explore the notion that might suggest unknown novel functions of PEG3 in regulating
different cellular processes and pathways (Chapter II and III).
In the first part of this dissertation, we characterized the ChIP-seq data systematically to
identify significant peaks of Peg3. We performed the feature analysis on the peaks, which
identified that majority of peaks were from the promoter region and a handful of peaks were from
the distal intergenic region. Motif analysis of Peg3 predicted a de novo motif with similar
characteristics to the previously described motif with a slight variation in non-critical bases and
length. The functional analysis further confirmed the role of PEG3 as a transcriptional repressor
and tumor suppressor. Combined, these results strongly suggest that PEG3 is a transcriptional
repressor, which functions by binding to the conserved motif sequence of the target genes. One of
the standout observations from this study was the unusually higher percentage of distal intergenic
PEG3 peaks, which has not been reported before. Given the known function of PEG3 as a binding
protein, it might be possible that PEG3 may be involved in indirect regulation of the target gene
by binding to the distal transcription regulators like enhancers. We predict that these are the
potential enhancer regions, which can affect the gene transcription even if they are few kilobases
away from the target gene (Heintzman & Ren, 2009; Visel et al., 2009). This would be an
interesting angle to pursue in the future. Characterization of such distal enhancers can be
performed by searching for certain histone marks. For instance, there is a relatively higher level of
histone H3 monomethylation on Lys 4 (H3K4me1) and histone H3 acetylation on Lys 27
(H3K27ac) in an active enhancer (Creyghton et al., 2010). Further analysis of such histone marks
using ChIP-seq and mass spectrometry to characterize the potential enhancers would solidify our
preliminary finding of the potential role of Peg3 as an indirect transcriptional regulator.
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The second part of the dissertation focused on assessing the functional role of PEG3 in
affecting lipogenesis. A previous study examining the genome-wide expression analysis indicated
that several genes from lipid metabolism were upregulated in Peg3 mutant mice (Kim et al., 2013).
In addition, a smaller body size with a higher fat level was observed in Peg3 deficient mice (Curley
et al., 2005). A recent generation of both reduced 0x dosage of Peg3 mouse (KO) and increased
2x dosages of Peg3 mouse (U1) by our group has made it fascinating to explore the effect of both
dosages on the lipogenesis pathways. Manual inspection ChIP-seq results unveiled the lipogenesis
pathway as a standout pathway since all the critical genes, including Acly, Idh1, Fasn, and Hmgcr,
had a noticeable peak in their promoter regions. Results showed that expression levels of Acly
responded opposite to the dosage of Peg3, especially in 14.5 dpc embryos. This, again, highlighted
the repressor role which has been demonstrated previously on several downstream genes, including
Msl1, Msl3, H19, and Oxtr (Frey et al., 2018; Ye et al., 2016, 2017).
One of the noteworthy observations was sex-biased results between WT and KO dosage
for Acly, Idh1, and Fasn in the lipogenesis pathway. In KO samples, females had upregulation of
Acly, whereas downregulation of Acly was observed in males compared to their WT counterparts
respectively. This was an intriguing observation since there might be quite a few levels of factors
contributing to sex-specific results. Both genes, Peg3 and Acly, and tissue of interest, mammary
gland, are sexually dimorphic and dynamic genes and tissue respectively (Fernandez et al., 2019;
He, Perera, et al., 2016; Macias & Hinck, 2012). This result was consistent with an explanation
from a previous study, which demonstrated the significant negative impact on the male compared
to the female due to the loss of Peg3 expression (He, Perera, et al., 2016). Similarly, higher
expression levels of Peg3 in males were also observed during late embryonic and perinatal stages,
when compared to females (Faisal et al., 2014). This study was further confirmed through the
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prominent sexually biased effect in adult mammary glands from our results. Overall, higher
expression of Acly, Idh1, and Fasn was observed in KO female, whereas lower of expression of
these genes in KO male supported the intra-locus sexual conflict theory. This result was also
supported by the previous breeding experiment performed in our lab that showed dramatic
phenotypic effects on males compared to females with the loss of the Peg3 expression, especially
higher percentage of lethality among male homozygotes (He, Perera, et al., 2016).
Both studies strongly hinted at the connection of Peg3 to tumor suppression. Functional
analysis from the first study using GO demonstrated the PEG3 as a transcription repressor through
its involvement in several transcriptional regulatory biological processes and complexes, whereas
KEGG pathways strongly hinted at PEG3 being a potential tumor suppressor. One of the
significant pathways observed was the Hippo signaling pathway, which has already been linked to
breast cancer (Cordenonsi et al., 2011). A separate study depicted the association of PEG3 with
breast cancer (M. Zhang & Zhang, 2020). These two independent studies infer the plausible role
of Peg3 in breast cancer through the Hippo pathway and could be an engaging area to pursue in
the future. The second study illustrating the relationship between the Peg3 and Acly can also be
explained in connection to tumorigenesis. Down-regulation of PEG3 has been demonstrated in
ovarian, breast, and cervical cancers (Feng et al., 2008; Nye et al., 2013; M. Zhang & Zhang,
2020). Human PEG3 has been linked as a tumor suppressor for several tumors and its decreased
expression levels were established in 18 different cancer types (Kim et al., 2015; M. Li et al.,
2017). PEG3 can also play a pivotal role in tumor suppression by inducing p53 mediated apoptosis
in association with SIAH1 (Relaix et al., 2000). Combining these results with overexpression of
ACLY to increase the lipid synthesis for promoting tumorigenesis, depicted in several tumors,
insinuate potential indirect involvement of Peg3 in tumors (C. Zhang et al., 2016). It might be
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prudent to suggest the potential upregulation of Acly in response to an absence of PEG3 for the
fulfillment of higher demand of energy and lipid culminates in rapid cell division. Rapid cell
division is one of the hallmarks of tumorigenesis. However, the molecular mechanism underlying
this interaction between Peg3 and Acly remained to be examined in the future.
Our ChIP-seq data solely focused on looking at the functional roles of Peg3 by comparing
WT and KO. It would be interesting to explore the global effect of Peg3 on gene expressions in
increased 2x gene dosage of Peg3 in both males and females using RNA-seq analysis. It might
also reveal an unknown functional aspect of Peg3 as it has been shown that males and females
respond differently to both decreased and increased dosages of Peg3. Even though the result from
the second study did not show predicted difference within two sexes in 2x dosage, we suspect two
reasons. First, the tissue we focused on was a mammary gland, which is only fully developed and
functional in females. Second, the target genes from the lipogenesis pathway are already critical
genes for the proper functioning of an organism so that their downregulation might be intolerable
in 2x dosage of Peg3.
Taken together, current research redefines the binding motif of PEG3, identifies the
potential novel biological processes and functions of PEG3, and examines the regulation of Acly
in controlling the lipogenesis pathway. Overall, these findings presented in this dissertation
contribute to further our understanding of the regulation and functional aspects of Peg3 and other
imprinted genes.
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APPENDIX A.
SUPPLEMENTAL DATA
Chapter 2
Table A2.1 Computational pipeline command line arguments. The following table shows the
detail of programs that were utilized for the computational pipeline.
1. Quality check using fastqc and multiqc
``` fastqc -o fastqc_results *.fastq
mutiqc . ```

2. Bowtie2 (used mm10 as index file)
``` bowtie2 -p <> -x <mm10_index> input.fastq -S output.sam ```

3. Samtools for filtering sam file and converting it to bam file
a. bash script for using
```
#!/bin/bash
sed '/random/d;/chrUn/d' $1.sam > $1_filtered.sam
# removes random chromosomes, and unaligned chromosomes from sam file
samtools view -S -b $1_filtered.sam > $1.bam
samtools view -c $1.bam
#counts the bam reads line
```
b. Run the script for the individual sam file
``` ./bam.sh <sample name> ```
c. Count bam file and subsample them to match both sample
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``` samtools view -b -s 1.875 <factor to decrease the file by> input.bam > output.bam ```

3.MACS2
``` macs2 callpeak -t treatment.bam -c control.bam -f BAM -g mm -n MAC2_output --bdg -q
0.05 ```
# MACS2 for bam file (-t) against input (-c) using mouse(mm) genome and create bedgraph
(bdg) file, and qvalue is 0.05, which is like padj value to ignore false positives.

4. Conversion of bedgraph to a bigwig for genome browser viewing
a. Download custom script for converting bedGraph to BigWig
``` wget http://hgdownload.soe.ucsc.edu/admin/exe/linux.x86_64.v369/bedGraphToBigWig ```
b. Download another script that downloads the mm10 chromosome sizes
``` wget http://hgdownload.soe.ucsc.edu/admin/exe/linux.x86_64.v369/fetchChromSizes ```
run the script
``` ./fetchChromSizes mm10 > mm10.chrom.sizes ```
c. Script for making bigwig from bedgraph
``` ./bedGraphToBigWig sample_treat_pileup.bdg mm10.chrom.sizes sample.bigwig ```
4. Homer
a. Make a tag directory for a bam file
``` makeTagDirectory sample_tagdir sample.bam ```
b. Find differential peaks between wt and ko using the tag directory
``` getDifferentialPeaks wt_peg3_peaks.narrowPeak wt_peg3_tagdir/ ko_peg3_tagdir/ >
wt_peg3_diff_peaks.txt ```
c. Finding Motifs with Homer
``` findMotifsGenome.pl wt_peg3_peaks.bed mm10 wt_peg3_motifs/ -size 200 -mask ```
d. Gene Ontology
``` annotatePeaks.pl [peak file] [genome version] -annStats annotate.log > output.tsv ```

5. Peak Annotation using ChIPseeker in R
a. Load the packages, install them following the instructions in the links above
install.packages("ChIPseeker ")
install.packages("TxDb.Mmusculus.UCSC.mm10.knownGene ")
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install.packages("rtracklayer ")
install.packages("org.Mm.eg.db ")

library(ChIPseeker)
library(TxDb.Mmusculus.UCSC.mm10.knownGene)
library(rtracklayer)
library("org.Mm.eg.db")
txdb <- TxDb.Mmusculus.UCSC.mm10.knownGene

# Read in the peaks for PEG3
peg3 <- import ("wt_peg3_peaks.bed", format = "BED")
peg3_anno<- annotatePeak(peg3, tssRegion=c(-3000, 3000),
TxDb=txdb, level = "gene", annoDb="org.Mm.eg.db",
sameStrand = FALSE, ignoreOverlap = FALSE,
overlap = "TSS")
# Visualization
plotAnnoPie(peg3_anno)
upsetplot(peg3_anno, vennpie=TRUE)

# Check the annotation
head(as.data.frame(peg3_anno))
# Save it to a text file to your computer
write.table(as.data.frame(peg3_anno), "Peg3_peaks_anno.txt", row.names =F, col.names=T)
b. Pathway enrichment analysis for the peaks
library(clusterProfiler)
# GO term enrichment
ego <- enrichGO(gene = as.data.frame(peg3_anno)$SYMBOL,
OrgDb = org.Mm.eg.db,
keytype = "SYMBOL",
ont = "BP",
pAdjustMethod = "BH",
pvalueCutoff = 0.01,
qvalueCutoff = 0.05)
# Visualization
dotplot(ego, showCategory = 20)
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# Kegg pathway enrichment
kk<- enrichKEGG(gene = as.data.frame(peg3_anno)$geneId,
organism = 'mmu',
pvalueCutoff = 0.05)
dotplot(kk, showCategory = 20, title = "Peg3 binding pathway enrichment", orderBy = "x" )
C. Heatmap of Chip-Seq data using ngs.plot for multiplot
a. ngs.plot utilizes the indexed bam file to create heatmap and average profile
```ngs.plot.r -G mm10 -R tss -C wt_peg3_sorted.bam:wt_input_sorted.bam -O wt_peg3vsInp.tss
-T ngs_peg3 -L 3000```
```ngs.plot.r -G mm10 -R tss -C ko_peg3_sorted.bam:ko_input_sorted.bam -O ko_peg3vsInp.tss
-T ngs_peg3 -L 3000```
b. hierarchical clustering and k-means clustering methods for comparing the WT and KO
samples.
# config file (config_peg3.txt) was created for a WT and KO bam-pair which is pair of indexed
bam files WT and Input as well as KO and Input bam.
# config_peg3.txt would be like this:
wt_peg3_sorted.bam:wt_input_sorted.bam
ko_peg3_sorted.bam:ko_input_sorted.bam

-1
-1

"wt_peg3"
"ko_peg3"

#final command to run clustering:
```ngs.plot.r -G mm10 -R genebody -L 3000 -C config_peg3.txt -O PEG3_KM -GO km```
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Table A2.2 List of ChIP-seq peaks of wild-type (WT) sample obtained from MACS2 analysis.

(Table A2.2 continued)
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(Table A2.2 continued)
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(Table A2.2 continued)
64
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Table A2.3 List of ChIP-seq peaks of knockout (KO) sample obtained from MACS2 analysis.

(Table A2.3 continued)
66

(Table A2.3 continued)
67

(Table A2.3 continued)
68
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Table A2.4 List of significant differential ChIP-seq peaks between wildtype (WT) and knockout
(KO) sample obtained from HOMER analysis.
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Chapter 3

Figure A3.1 In vivo binding of PEG3 to the promoter of Idh1. The binding of PEG3 to Idh1 was
examined using ChIP-seq and individual ChIP experiments. (A) Forty-one kb genomic regions
surrounding Idh1 from ChIP-seq data. The peak was observed on the promoter region of Idh1 in
WT sample. (B) In vivo binding of PEG3 to Idh1 in the MEF and brain. Individual ChIP
experiment confirmed the binding of PEG3 to the promoter region of Idh1 in both MEF and brain
samples.
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Figure A3.2 In vivo binding of PEG3 to the promoter of Hmgcr. ChIP-seq and individual ChIP
experiments were performed to assess the binding of PEG3 to Hmgcr. (A) Thirty-two kb genomic
regions encompassing Hmgcr. ChIP-seq data showed the peak on the promoter region of Hmgcr in
WT sample. (B) In vivo binding of PEG3 to Hmgcr in the MEF cells. Individual ChIP experiment
confirmed the binding of PEG3 to the promoter region of Hmgcr in MEF samples.
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Figure A3.3 In vivo binding of PEG3 to the promoter of Fasn. ChIP -seq and individual ChIP
experiments were performed to analyze the binding of PEG3 to Fasn. (A) Twenty-eight kb
genomic regions surrounding Fasn from the ChIP-seq data. The peak on the promoter region
of Idh1 was observed in WT. (B) In vivo binding of PEG3 to Idh1 in the MEF cells. Individual
ChIP experiment confirmed the binding of PEG3 to the promoter region of Idh1 in MEF samples.
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APPENDIX B.
PERMISSION FOR REUSE FOR CHAPTER 3
Previously Published in PLOS ONE: Ghimire S, Kim J. PEG3 controls lipogenesis through ACLY.
PLoS One. 2021;16: e0252354. doi:10.1371/journal.pone.0252354
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